Pfizer finalizes $785M settlement to resolve allegations of underpaying Medicaid rebates

Wyeth, a subsidiary of pharmaceutical company Pfizer, finalized a $784.6 million settlement with the federal government and individual states to resolve allegations of underpaying rebates owed under the Medicaid Drug Rebate Program. New York-based Pfizer first announced The terms of the agreement in February. The Pennsylvania Attorney General’s office said between 2001 and 2006 Wyeth knowingly underpaid rebates owed under the Medicaid Drug Rebate Program for the sales of Protonix Oral and Protonix…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news